RBC Capital Maintains Outperform on Chemed, Raises Price Target to $604

Chemed Corporation +1.37% Post

Chemed Corporation

CHE

596.69

596.71

+1.37%

0.00% Post

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE: CHE) with a Outperform and raises the price target from $576 to $604.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via